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Relationship of the mucosal microbiota to gastrointestinal inflammation
and small cell intestinal lymphoma in cats
Abstract
Background: The gastrointestinal (GI) microbiota in healthy cats is altered in IBD. Little research has been
performed to identify whether specific bacterial groups are associated with small cell GI lymphoma (LSA).
Hypothesis: Mucosal bacteria, including Enterobacteriaceae and Fusobacterium spp., are abundant in
intestinal biopsies of cats with small cell GI LSA compared to cats with IBD.
Animals: Fourteen cats with IBD and 14 cats with small cell GI LSA.
Methods: Retrospective case control study. A search of the medical records was performed to identify cats
diagnosed with IBD and with GI LSA. Bacterial groups identified by FISH in GI biopsies were compared
between cohorts and correlated to CD11b+ and NF‐κB expression.
Results: Fusobacterium spp. (median; IQR bacteria/region) were higher in cats with small cell GI LSA in ileal
(527; 455.5 – 661.5; P = .046) and colonic (404.5; 328.8 – 455.5; P = .016) adherent mucus, and combined
colonic compartments (free mucus, adherent mucus, attaching to epithelium) (8; 0 – 336; P = .017)
compared to cats with IBD (ileum: 67; 31.5 – 259; colon: 142.5; 82.3 – 434.5; combined: 3; 0 – 34).
Bacteroides spp. were higher in ileal adherent mucus (P = .036) and 3 combined ileal compartments (P =
.034) of cats with small cell GI LSA. There were significant correlations between Fusobacterium spp. totals
and CD11b+ cell (P = .009; rs .476) and NF‐κB expression (P = .004; rs .523).
Conclusions: The bacterial alterations appreciated might be influential in development of small cell GI LSA,
and should drive further studies to elucidate the effects of microbial‐mediated inflammation on GI cancer
progression.
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Background: The gastrointestinal (GI) microbiota in healthy cats is altered in IBD. Little research
has been performed to identify whether specific bacterial groups are associated with small cell
GI lymphoma (LSA).
Hypothesis: Mucosal bacteria, including Enterobacteriaceae and Fusobacterium spp., are abun-
dant in intestinal biopsies of cats with small cell GI LSA compared to cats with IBD.
Animals: Fourteen cats with IBD and 14 cats with small cell GI LSA.
Methods: Retrospective case control study. A search of the medical records was performed to
identify cats diagnosed with IBD and with GI LSA. Bacterial groups identified by FISH in GI biop-
sies were compared between cohorts and correlated to CD11b+ and NF-κB expression.
Results: Fusobacterium spp. (median; IQR bacteria/region) were higher in cats with small cell GI
LSA in ileal (527; 455.5 – 661.5; P = .046) and colonic (404.5; 328.8 – 455.5; P = .016) adherent
mucus, and combined colonic compartments (free mucus, adherent mucus, attaching to epithe-
lium) (8; 0 – 336; P = .017) compared to cats with IBD (ileum: 67; 31.5 – 259; colon: 142.5;
82.3 – 434.5; combined: 3; 0 – 34). Bacteroides spp. were higher in ileal adherent mucus
(P = .036) and 3 combined ileal compartments (P = .034) of cats with small cell GI LSA. There
were significant correlations between Fusobacterium spp. totals and CD11b+ cell (P = .009; rs
.476) and NF-κB expression (P = .004; rs .523).
Conclusions: The bacterial alterations appreciated might be influential in development of small
cell GI LSA, and should drive further studies to elucidate the effects of microbial-mediated
inflammation on GI cancer progression.
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CD11b+, Feline microbiota, Fusobacterium, Gastrointestinal lymphoma, Inflammatory bowel
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1 | INTRODUCTION
Diagnosis of small cell gastrointestinal (GI) lymphoma (LSA) in cats
increased six-fold over a four-decade period spanning from 1964
through 2004, highlighting the growing clinical importance of this dis-
ease.1 Frequent identification of the disease continues today, most nota-
bly in cats with chronic weight loss, vomiting, decreased appetite and
diarrhea. Small cell GI LSA closely resembles feline inflammatory bowel
disease (IBD) in its clinical presentation,2 with both diseases having
poorly defined etiologies. Various risk factors including genetic and
molecular alterations,3–5 diet,3,6,7 and chronic inflammation8–10 have
been linked to the development of both disorders. Still other studies
have suggested an association between chronic mucosal inflammation
and the progression of IBD to pronounced dysplasia in the GI tract.11–14
Although the microbiota is intimately involved in GI homeostasis
and immune balance, several studies in animal models and humans
with cancer incriminate bacterial-induced chronic intestinal inflamma-
tion as promoting a local environment favorable for malignant trans-
formation, including lymphomagenesis.11–14 Increased numbers of
mucosal-adherent bacteria were observed in cats with duodenal
IBD,10 while invasive bacteria were observed within blood vessels and
serosa of cats with large cell lymphoma.9 These collective observa-
tions suggest that altered microbial composition (e.g. dysbiosis) is
associated with development of benign mixed mucosal inflammation
(lymphoplasmacytic enteritis with IBD) and GI lymphoid
malignancy.9,10,15–18 Microbial imbalances have also been implicated
in the pathogenesis of approximately 20% of all human malignancies,
including GI neoplasia such as colorectal adenocarcinomas and gastric
carcinomas.19–21 Both chronic, high-grade inflammation of disorders
such as feline IBD, and lower grade smoldering inflammation attribut-
able to pro-inflammatory bacteria (e.g. Helicobacter spp., Enterobac-
teriaceae, Fusobacterium spp.) might drive a tumor-permissive milieu
characterized by mucosal infiltration with specialized effector cells,
including CD11b+ myeloid cell derived macrophages, as observed in
humans, and rodent models.9,19,21,22
Differentiated CD11b+ myeloid cells play an important role in
tumor progression and angiogenesis in rodent models and humans
with colorectal cancer (CRC).19,23 Nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB), a protein complex of transcrip-
tion factors, is involved in immune regulation, DNA transcription, and
pro-inflammatory cytokine and chemokine production.24 This protein
complex is also involved in activation of effector cells through toll-like
receptors (TLRs) in response to GI micro-organisms. Dysregulation of
the activation of NF-κB can lead to overproduction of pro-
inflammatory cytokines and cell transformation, triggering the devel-
opment of cancers in humans.25–27
We hypothesized that pro-inflammatory bacteria, including Enter-
obacteriaceae and Fusobacterium spp. are abundant in the intestinal
biopsies of cats with small cell GI LSA relative to cats with IBD. An
objective of this study was to investigate the potential relationship
between mucosal bacteria and the mucosal expression of NF-κB and
infiltrating CD11b+ immune cells in GI biopsies of cats with small cell
GI LSA versus GI biopsies of cats with IBD.
2 | MATERIALS AND METHODS
2.1 | Study Design
This study was a retrospective study involving 3 study centers, VDx
Veterinary Diagnostics Laboratory, Davis CA; the University of
Camerino Veterinary Teaching Hospital, Italy and Iowa State Univer-
sity, Ames IA. The medical records of each facility were reviewed to
identify cats having GI endoscopic or laparoscopic derived diagnosis
of histologic IBD or small cell GI LSA from January 2010 to January
2015. Fourteen cats with IBD and 14 cats with small cell GI LSA were
included in the study. Inclusion criteria was comprised of complete
medical histories, the performance of hematologic and serum bio-
chemical analysis, and measurement of serum T4 in all cats. Serology
for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus
(FIV) infections, diagnostic imaging, and serum cobalamin levels were
also assessed in most cats. Cats were also either tested for intestinal
parasites via fecal examinations, dewormed or had deworming per-
formed in the face of negative fecal examinations before biopsies
were collected. All cats in both study cohorts tested negative for
intestinal parasite ova on fecal examinations. Histopathologic exami-
nation of intestinal biopsy specimens after hematoxylin-eosin
(HE) staining and immunophenotyping (e.g. IHC stains for CD21,
CD79a [B-lymphocytes] and CD3 [T-lymphocytes]) was performed on
each cat to determine a final diagnosis of IBD or small cell GI LSA. In
some instances, there was overlap in immunohistopathologic features
necessitating performance of polymerase chain reaction for antigen
receptor rearrangement (PARR) to confirm a final diagnosis of IBD
versus small cell GI LSA.
2.2 | Fluorescence in Situ Hybridization (FISH)
Formalin-fixed embedded tissue sections were mounted on glass
slides and evaluated by fluorescence in situ hybridization (FISH) as
previously described.8 In brief, paraffin-embedded tissue specimens
were deparaffinized using an automated system by passage through
xylene (3 x 10 min), 100% alcohol (2 x 5 min), 95% ethanol (5 min) and
lastly 70% ethanol (5 min). The slides were next immediately trans-
ported in deionized water to the DNA testing laboratory where they
were air dried prior to hybridization. FISH probes of interest, 5’-
labeled with either Cy-3 or FITCa were reconstituted with DNAse-free
water and diluted to a working concentration of 5ng/μL (Table 1).
For total bacterial counts, Eub338-FITC was used.28 For other
analyses, specific probes targeting Clostridium spp. (Erec482),29
Bacteroides-Prevotella group (Bacto1080),30 Fusobacterium spp.
(Fuso0664),31 Enterobacteriaceae (Ebac1790),32 Helicobacter spp.
(Hel717),33 and Faecalibacterium spp. (Faecali698),34 were labeled with
Cy-3 and were applied simultaneously with the universal bacterial probe
Eub338-FITC. This probe array was selected to identify specific bacterial
groups and individual bacterial species previously shown to be relevant in
the pathogenesis of intestinal cancers in humans, rodents, and
dogs.9,14,19,22,23,27,35–54
Tissue sections were bathed in 30μL of DNA-probe-hybridization
buffer mix in a hybridization chamber maintained at 54C overnight
(12 hours). Buffer 1 (20mM Tris, 0.9M NaCl, 0.1% SDS, 20% Formamide,
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10% Dextran sulfate) was used for the hybridization of Eub338, Erec482,
Bacto1080, Fuso0664, Ebac1790 and Faecali698. Buffer 2 (20mM Tris,
0.9M NaCl, 0.1% SDS, 40% Formamide) was used for the hybridization
of Hel717. Washing was then performed using wash buffer (hybridiza-
tion buffer without SDS), the slides were rinsed with sterile water, then
allowed to air-dry, and mounted with SlowFade Gold mounting mediab
and 22x22-1 glass cover slipa. Probe specificity was confirmed in pilot
studies by combining the irrelevant probe non-Eub338-FITC with
Eub338-Cy-3, and through hybridization experiments with pure bacterial
isolates to screen for non-selective hybridization.
2.3 | In Situ Quantification of Mucosal Bacteria
Associated with Biopsy Specimens
Bacteria were visualized and quantified using an Eclipse TE2000-E
fluorescence microscopec. Images were captured with a CoolSnap EZ
camerad and bacterial enumeration was performed using MetaMorph
softwaree. A minimum of 3 separate hybridized intestinal tissue sec-
tions were evaluated for their bacterial content. Bacterial quantifica-
tion was performed in 10 representative mucosal fields of each
hybridized tissue section of formalin-fixed, paraffin embedded biopsy
specimens. A hybridized tissue section was first visualized at 200x
magnification to locate the center of each tissue section. Then sur-
rounding fields of bacterial populations were subsequently selected,
and quantified using a 60x Plan Apo oil objective with an optional
1.5x multiplier lens. Bacterial counts were obtained randomly in
3 mucosal fields in 2 of the 3 hybridized tissue sections, and randomly
in 4 views on the third hybridized tissue section, accounting for
10 views for bacterial quantification in total. The ten fields counted
included bacteria located within 4 well-defined mucosal compart-
ments: (1) bacteria found within free mucus, (2) bacteria localized
within adherent mucus, (3) bacteria attached to the surface epithe-
lium, and (4) bacteria invasive within the mucosa (Figure 1).
2.4 | Immunohistochemical Assessment of the
Number of CD11b+ Cells and Mucosal NF-κB
Expression
The number of mucosal CD11b+ myeloid cells, and nuclear factor –
kappa B (NF-κB) expression were quantified in intestinal tissues of all
28 cats. This included 14 cats diagnosed with IBD and 14 cats diag-
nosed with small cell GI LSA. For IHC evaluation, paraffin embedded
tissue sections were rehydrated and neutralized for endogenous
peroxidases with 3% hydrogen peroxide for 5 minutes followed by
rinsing for 5 minutes in distilled water. For antigen retrieval, the heat-
induced epitope retrieval (HIER) method was selected, on the basis of
previous experiences showing better results with antigens, such as
CD11b+, that might require more efficient breakage of methylene
bridges formed during formalin fixation and allowing antibody to bind.
In brief, slides were incubated in an universal antigen retrieval buffer
(Universal Heat-Mediated Antigen Retrieval Reagent kit)f, used in a
water bath set to 140F and allowing the slides to incubate in retrieval
solution overnight. Non-specific binding was blocked by incubation of
slides for 10 minutes with a protein-blocking agentg before application
of the primary antibody. Slides were then incubated overnight in a
moist-chamber with the following primary antibodies: canine cross-
reactive monoclonal antibody against NF-κB (p65)h,55 diluted 1 : 50,
and a goat polyclonal to CD11b+ (anti-CD11b+ antibody - ref. N
ab62817)f diluted 1 : 50. The immunoreaction with streptavidin–
immunoperoxidasei was visualized with 3,30-diaminobenzidine sub-
stratej. Tissues were counterstained with Mayer's hematoxylin
(Figure 2). For negative IHC controls, the primary antibodies were
omitted. Sections of feline and canine spleen and tonsil served as
TABLE 1 Oligonucleotide probes used for fluorescence in situ hybridization (FISH) and bacterial quantification
Probe Target Sequence (5’ ! 3’)
Eub338 Eubacteria GCT GCC TCC CGT AGG AGT
Erec482 Clostridium coccoides-E. rectale cluster GCT TCT TAG TCA RGT ACC G
Ebac1790 Enterobacteriaceae CGT GTT TGC ACA GTG CTG
Bacto1080 Bacteroides spp.Prevotella spp. GCA CTT AAG CCG ACA CCT
Hel717 Helicobacter spp. AGG TCG CCT TCG CAA TGA GTA
Faecali698 Faecalibacterium spp. GTG CCC AGT AGG CCG CCT TC
Fuso0664 Fusobacterium spp. CTT GTA GTT CCG CYT ACC TC
FIGURE 1 Mucosal compartments for bacterial quantification.FM,
bacteria within free mucus within the GI lumen; AM, bacteria within
adherent mucus adhered to the epithelia; A, bacteria directly
attaching to surface epithelia; I, bacteria invasive within the mucosa.
Three-color fluorescence in situ hybridization (FISH) of Bacteroides
spp. identified in ileal biopsies of a cat with small cell GI LSA.Cy-
3-labeled Bacteroides spp. (labeled orange) localized within an ileal
biopsy specimen (FM; AM; A; and I). The free (FM) and adherent
mucus (AM) are also occupied by other bacteria (total bacteria labeled
green with FITC-Eub). The dark blue structures are epithelial cell
nuclei stained with DAPI
GARRAWAY ET AL. 3
FIGURE 2 IHC staining for CD11b+ and NF-κB primary antibodies in ileal and colonic biopsies of cats with IBD and small cell GI LSA.
(A) CD11b+myeloid cell staining in the ileum of a cat with IBD (cat 1). Cross sectional view of ileal villi after IHC staining with a goat polyclonal
antibody to CD11b+ as represented by the brown chromophore staining amongst the epithelium and in the lamina propria. (B) NF-κB staining in
the ileum of a cat with IBD (cat 1). Cross sectional view of ileal villi after IHC staining with a canine cross-reactive monoclonal antibody against
NF-κB (p65) as represented by the brown chromophore staining amongst the epithelium and in the lamina propria. (C) CD11b+ staining in the
ileum of a cat with small cell GI LSA (cat 2). Longitudinal view of ileal villi after IHC staining with a goat polyclonal antibody to CD11b+ as
represented by the brown chromophore staining amongst the epithelium and in the lamina propria. (D) NF-κB staining in the ileum of a cat with
small cell GI LSA (cat 2). Longitudinal view of ileal villi after IHC staining with a canine cross-reactive monoclonal antibody against NF-κB (p65) as
represented by the brown chromophore amongst the epithelium and in the lamina propria. (E) CD11b+ staining in the colon of a cat with small cell
GI LSA (cat 3). Longitudinal and cross sectional views of colonic mucosa and lamina propria after IHC staining with a goat polyclonal antibody to
CD11b+ as represented by the brown chromophore staining amongst the epithelium and in the lamina propria. (F) NF-κB staining in the colon of a
cat with small cell GI LSA (cat 3). Longitudinal and cross sectional views of colonic mucosa and lamina propria after IHC staining with a canine
cross-reactive monoclonal antibody against NF-κB (p65) as represented by the brown chromophore staining amongst the epithelium and in the
lamina propria.All scale bars, 200 μm
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positive control tissues for both NF-κB (p65) and CD11b+ cell staining.
Finally, isotype controls were used as negative controls to help differ-
entiate eventual non-specific background signal from specific anti-
body signal, by the use of primary antibodies lacking specificity to the
target, but matching the class and type of the primary antibody used
in the IHC studies.
For assessment of intestinal NF-κB (p65) and CD11b+ cells, the
cells were quantified in select compartments of the GI tract biopsies
(small intestine: villi, basal crypt area, villus-crypt junction; large intes-
tine: apical crypt area, basal crypt area). All cellular types were evalu-
ated using a light microscope (Carl Zeiss)k, a × 40 objective, a ×
10 eyepiece, and a square eyepiece graticule (10 × 10 squares, having
a total area of 62,500 μm2). Ten appropriate fields were chosen for
each compartment and arithmetic means were calculated for each
intestinal region. Results were expressed as IHC positive cells per
62,500 μm2. Cells on the margins of the tissue sections were not con-
sidered for evaluation to avoid inflation of positive cell numbers.
The numbers of mucosal NF-κB (p65) expressing cells and
CD11b+ cells were quantified using an image-analysis system consist-
ing of the previously mentioned light microscope (Carl Zeiss)k
attached to a Javelin JE3462 high-resolution camera and a personal
computer equipped with a Coreco-Oculus OC-TCX frame grabber and
high-resolution monitor. Computerized color-image analysis was per-
formed by using Image-Pro Plus softwarel. The area of each biopsy in
all cross sections in every cat was recorded. For each cat, the total
bioptic area was calculated as the sum of the areas of all fields in all
bioptic cross sections on one slide. The NF-κB (p65) expressing cells
and CD11b+ cells were counted per section, and stained cell densities
were expressed as the number of mononuclear cells per square milli-
meter of analyzed bioptic area.56
2.5 | Statistical Analysis
Tabular data were organized by probe, organ, mucosal compartment
and disease group. Mean, median, standard deviation, minimum, and
maximum values were calculated from the absolute bacterial counts.
Normality of data was assessed visually by histograms and Q-Q plots.
If data were not found to be normally distributed, they were log-
transformed and reassessed. Median values were compared among
groups for significance using the Wilcoxon rank sum test. Analyses
were considered significant at P < .05. All graphs were constructed
using non-log-transformed, actual raw data.
Associations between bacterial numbers (identified by FISH) and
the numbers of CD11b+ cells and NF-κB expressing cells were
assessed using Spearman’s rank correlation and tested for signifi-
cance. Significance was determined as P < .05. Sample size for enroll-
ment was calculated after consultation with a statistician and was
based on the desired power and variability in the number of CD11b+
cells and NF-κB expressing cells observed in IBD versus small cell GI
LSA feline cohorts. Randomization of 12 cats per group would give a
power of 80% to detect differences in expression of CD11b+ cells and
NF-κB expressing cells between cohorts at the .05 significance level.
All analyses were made using SAS 9.4m.
3 | RESULTS
3.1 | Final Histopathologic Diagnoses
Fourteen cats were diagnosed with IBD based on histopathologic
assessment of the mucosal cellular infiltrate (lymphoplasmacytic) after
H&E, immunophenotypic staining and PARR as an adjunct diagnostic
in equivocal cases. GI biopsies in 9 of 14 of these cats exhibited a
30% to 60% heterogenous population of small to intermediate lym-
phocytes and plasma cells invading the lamina propria, with mild but
varying numbers of neutrophilic and eosinophilic cellular infiltrates per
any given 400x magnification field assessed after H&E staining via
microscopy. The diagnosis of IBD in these cats was supported by IHC
showing relatively evenly mixed CD3 and CD21 or CD79a cellular
positivity without immunophenotypic evidence of clustering of either
T-cell or B-cell populations. Sparse numbers of intraepithelial lympho-
cytes (i.e. approximately 0 to 20 per 100 villous enterocytes) were
also appreciated in limited villous epithelium and less commonly in
crypt epithelium. Additionally, PARR was performed on intestinal
biopsies from the remaining 5 of these 14 cats to confirm diagnosis of
a polyclonal lymphocyte mucosal population, as these biopsies were
assessed as having areas of mild to moderate villous blunting and
fusion with crypt effacement on histopathologic assessment, greater
numbers of intraepithelial lymphocytes in both villous and crypt epi-
thelium and rare, patchy areas of moderately heavy monomorphous
lymphoid infiltrates of small to intermediate-sized CD3 staining
lymphocytes .
Fourteen cats were diagnosed with small cell GI LSA based on
H&E stains and immunophenotyping, with 1 cat requiring PARR to
confirm a final diagnosis. Thirteen of these 14 cats showed histopath-
ologic evidence of moderate to marked villous blunting and fusion
with crypt effacement after H&E staining. Moderate to marked intrae-
pithelial villous and crypt lymphocytes (i.e. more than 40 per 100 vil-
lous enterocytes) and diffuse heavy effacement of the lamina propria
with a heavy monomorphous lymphoid infiltrate of small to
intermediate-sized CD3 staining lymphocytes, occasionally with
sparse CD21/CD79a positive cells, were also appreciated after IHC
staining. The occasional sparse CD21/CD79a positive cells were sus-
pected to represent a mild inflammatory background. The 1 cat that
required PARR to confirm the diagnosis of small cell GI LSA was
assessed as having similar villous and crypt histopathologic features
but exhibited a mild number of eosinophils and neutrophils infiltrating
the lamina propria, minimal intraepithelial lymphocytes and patchy
areas of monomorphous lymphoid infiltrate with varying areas of
mixed T and B-cell populations, suggesting possible polyclonality.
3.2 | Demographics for Cats with IBD and Small Cell
GI LSA
Of the 14 cats diagnosed with IBD, 7 were castrated male and 7 were
spayed female. Nine of these cats were domestic shorthairs, and there
was 1 cat each of domestic longhair, Lynx Point, Savannah, Siamese,
and Ocicat. Of the 14 cats diagnosed with small cell GI LSA, 6 were
castrated male, 7 were spayed female, and sex and neuter statuses
were not reported in the medical record for 1 cat. Eleven of these cats
GARRAWAY ET AL. 5
were domestic shorthairs, and there was 1 cat each of domestic long-
hair, Himalayan, and Maine Coon. Histories were available for all
28 cats. Duration of clinical signs for each cat was reported as at least
3 weeks prior to presentation. Clinical signs of vomiting (n = 24) and
weight loss (n = 13) were noted most frequently with some cats also
exhibiting variable hyporexia (n = 9), small bowel diarrhea, large bowel
diarrhea, or both (n = 10) and hematochezia (n = 2). In general, cats
with small cell GI LSA were older than cats with IBD (small cell GI
LSA: mean 10.9, standard deviation 3.35; IBD: mean 7.4, standard
deviation 3.68; P = .009). Serum T4 measurements were within refer-
ence range for all cats (n = 28). Cats in which FeLV and FIV status
were assessed (10 cats with IBD, and 14 cats with small cell GI LSA)
were all negative. Serum cobalamin measurements were available for
11 cats (5 with IBD and 6 with small cell GI LSA). One of the 5 cats
with IBD with reported serum cobalamin concentrations had a cobala-
min level less than 300ng/L and 4 of the 6 small cell GI LSA cats with
reported serum cobalamin concentrations had cobalamin measure-
ments less than 300ng/L. Abdominal ultrasound findings were avail-
able in 22 of the 28 cats (10 cats with IBD and 12 cats with small cell
GI LSA). The remaining 6 cats either did not have abdominal imaging
performed or the report was excluded from the medical records. Of
the cats with abdominal ultrasounds performed, 10 had normal gas-
trointestinal wall thickness (7 cats with IBD and 3 cats with small cell
GI LSA) and 12 had diffuse thickening of the GI muscularis (3 cats with
IBD and 9 cats with small cell GI LSA). Five of the cats with IBD and
9 of the cats with small cell GI LSA had enlarged mesenteric lymph
nodes. In the remaining cats with abdominal imaging performed,
lymph nodes were noted as normal in size.
3.3 | Quantification and Spatial Distribution of
Mucosal Bacteria Determined by FISH
Only few bacteria were identified as invasive within the intestinal
mucosal biopsies. Therefore, bacterial quantification was performed in
the 3 other mucosal compartments (free mucus, adherent mucus,
attaching to surface epithelia) (Table 2) and separately in adherent
mucus (Table 3), in both the ileal and the colonic biopsies. Gastrointes-
tinal biopsies of cats with small cell GI LSA had significantly increased
numbers of total Fusobacterium spp. bacteria in the 3 combined muco-
sal compartments of the colon (P = .017) compared to GI biopsies of
cats with IBD (Table 2). Total Fusobacteria spp. bacteria in the 3 com-
bined mucosal compartments of ileal biopsies of cats with small cell GI
LSA was not statisticaly significanct (P = .059) compared to ileal biop-
sies of cats with IBD (Table 2). Gastrointestinal biopsies of cats with
small cell GI LSA had significantly increased numbers of total Fusobac-
teria spp. bacteria in the adherent mucus compartments of the ileum
(P = .046) and colon (P = .016) versus GI biopsies of cats with IBD
(Table 3). There was a significantly increased number of Bacteroides
spp. bacteria in the 3 combined ileal mucosal compartments (P = .034)
(Table 2) and in the ileal adherent mucus (P = .036) (Table 3) of GI
biopsies of cats with small cell GI LSA compared to GI biopsies of cats
with IBD. The numbers of total bacteria, Clostridium spp., Enterobac-
teriaceae, Helicobacter spp. and Faecalibacterium spp. were not signifi-
cantly different when comparing the colonic and ileal biopsies of cats
with IBD relative to the biopsies of cats with small cell GI LSA.
The amount of each species of bacteria evaluated were subjec-
tively observed to be more prevalent in the adherent mucus layer ver-
sus the free mucus, attached to the surface epithelia, and invasive
within the mucosa, including for Fusobacterium spp. and Bacteroides
spp. bacteria (Figure 3 and 4).
3.4 | Number of Mucosal CD11b+ Myeloid Cells and
NF-κB Expression
Cats with small cell GI LSA had significantly increased numbers of
CD11b+ cells within the lamina propria of both ileal (median = 503;
min 30, max 1985; P = .012) and colonic biopsies (median = 77; min
13, max 2858; P < .0001) versus cats with IBD (Figure 5). Cats with
small cell GI LSA also had significantly increased expression of NF-κB
in the lamina propria of both ileal (median = 750; min 69, max 2227;
P = .0055) and colonic biopsies (median = 154; min 40, max 3581; P <
.0001) when compared to cats with IBD (Figure 6). Additionally, data
analysis showed a positive correlation between the total numbers of
Fusobacterium spp. bacteria and the total numbers of CD11b+ cells
(P = .009; rs .476) as well as cells expressing NF-κB (P = .004; rs .523)
as assessed by spearman correlation coefficients.
4 | DISCUSSION
Major bacterial phyla identified in feces of healthy cats include Enter-
obacteriaceae, Bacteroides spp., Helicobacter spp., Fusobacterium spp.
and members of Firmicutes, including Clostridium spp. clusters IV and
TABLE 2 Total bacteria in 3 combined compartments (free mucus,
adherent mucus, attaching to surface epithelia). data has been logged
transformed to control for variability, and are reported as mean and
standard deviation of the transformed data
Probe Group Ileum Colon
Eub338 IBD 5.52  1.92 6.56  .65
LSA 6.75  .37 6.55  .39
Erec482 IBD 4.95  2.13 5.59  1.23
LSA 6.19  .77 5.86  .78
Ebac1790 IBD 4.36  2.47 4.33  1.87
LSA 3.98  1.75 4.8  1.14
Bacto1080 IBD 5.64  1.01 5.91  1.59
LSA 6.6  .38a 6  1.17
Hel717 IBD 1.54  1.6 1.97  1.82
LSA 2.07  1.07 2.27  1.71
Faecali698 IBD 4.62  2.13 5.12  1.71
LSA 5.95  .75 5.35  1.27
Fuso0664 IBD 4.6  2.14 5.14  1.27
LSA 6.32  .52 6.14  .66b
IBD, inflammatory bowel disease cats; LSA, small cell gastrointestinal lym-
phoma cats. (total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats).
a Mean Bacteroides spp. bacterial count in ileal biopsies of small cell GI LSA
cats significantly higher than in ileal biopsies of cats with IBD (P = .034).
b Mean Fusobacterium spp. bacterial count in colonic biopsies of small cell
GI LSA cats significantly higher than in colonic biopsies of cats with IBD
(P = .017).
Eub338, total bacteria; Erec482, Clostridium spp.; Ebac1790, Enterobacter-
iaceae; Bacto1080, Bacteroides-Prevotella group; Hel717, Helicobacter spp.;
Faecali698, Faecalibacterium spp.; Fuso0664, Fusobacterium spp.
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XIVa, and Faecalibacterum spp.37,39,49,57 Compared to earlier studies
performed in healthy cats, we chose to investigate the spatial distribu-
tion of the mucosal microbiota of ileal and colonic biopsies using FISH
techniques in 2 important and clinically overlapping disease cohorts,
cats with IBD and cats with small cell GI LSA. Our results indicate that
the numbers of mucosa-associated Fusobacterium spp. and Bacteroides
spp. were increased in the ileal biopsies of cats with small cell GI LSA
compared to the ileal biopsies of cats with IBD, while the numbers of
mucosa-associated Fusobacterium spp. bacteria were also increased in
the colonic biopsies of cats with small cell GI LSA compared to cats
with IBD. Furthermore, the numbers of Fusobacteria spp. in adherent
mucus were strongly associated with increased numbers of CD11b+
cells and up-regulated mucosal expression of NF-κB in GI biopsies of
cats with small cell GI LSA compared to GI biopsies of cats with IBD.
In humans, some Fusobacterium spp., including Fusobacterium
nucleatum, have been associated with an increased risk for colorectal
and pancreatic cancers, as well as some oral squamous cell carcino-
mas.38,42,44,52 Fusobacterium nucleatum numbers are significantly cor-
related with tumor size, and shortened survival times in a population
of human Japanese patients with later stage CRC compared to earlier
stages.53 These findings, as well as additional observations in rodent
models and humans with CRC suggest that chronic inflammatory dis-
ease of the GI tract is a potential risk factor for the development of
additional channels for amplified inflammatory processes, aneuploidy,
high-grade dysplasia, metaplasia and loss of cellular proliferative
checkpoints, all of which are processes that can be appreciated in
malignancy.13,19,54,58,59 The increased numbers of mucosal Fusobac-
terium spp. bacteria in GI biopsies of cats with GI LSA relative to GI
biopsies of cats with IBD noted in the current study, although possibly
just an effect of the GI malignancy, could also be associated with a
potential progression from high grade chronic lymphoplasmacytic
inflammation to inflammation-mediated lymphoid intestinal cancer.
Although incompletely understood, GI inflammation-mediated
progression to cancer development might involve bacterial toxin pro-
duction, release of alarmins, gut biofilm modification, dysregulation of
gut barrier function, suppression of anti-inflammatory mediators and
transition through an element of high grade dysplasia to cell damage
and aneuploidy.13,19,35,40,60–62 Fusobacterium spp. is pro-inflammatory,
exhibits adhesive and invasive properties via virulence factors
(i.e., FadA, fusobacterium autotransporter protein 2 and fusobacterial
outer membrane protein A), and promotes pro-oncogenic features
which might contribute to accelerated tumor growth and tumor bur-
den.38,47,54 Increased Fusobacterium nucleatum is associated with an
increase in adenoma formation and accelerated small intestinal adeno-
carcinoma development in rodent models of GI neoplasia.41 Coupled
TABLE 3 Total bacteria in adherent mucus. Data has been logged
transformed to control for variability, and are reported as mean and
standard deviation of the transformed data
Probe Group Ileum Colon
Eub338 IBD 5.33  2.04 6.51  .66
LSA 6.72  .38 6.5  .41
Erec482 IBD 4.9  2.11 5.51  1.33
LSA 6.09  .97 5.8  .81
Ebac1790 IBD 4.34  2.46 4.25  1.91
LSA 3.67  2.13 4.72  1.18
Bacto1080 IBD 5.43  1.23 5.76  1.86
LSA 6.57  .38a 5.95  1.25
Hel717 IBD 1.45  1.53 1.86  1.7
LSA 1.99  1.1 2.04  1.82
Faecali698 IBD 4.57  2.13 5.03  1.72
LSA 5.94  .74 5.2  1.59
Fuso0664 IBD 4.4  2.18 5.06  1.29
LSA 6.28  .56b 6.1  .7c
IBD, inflammatory bowel disease cats; LSA, small cell gastrointestinal lym-
phoma cats. (total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats).
a Mean Bacteroides spp. bacterial count in ileal biopsies of small cell GI LSA
cats significantly higher than in ileal biopsies of cats with IBD (P = .036).
b Mean Fusobacterium spp. bacterial count in ileal biopsies of small cell GI LSA
cats significantly higher than in ileal biopsies of cats with IBD (P = .046).
c Mean Fusobacterium spp. count in colonic biopsies of small cell GI LSA cats
significantly higher than in colonic biopsies of cats with IBD (P = .016).
Eub338, total bacteria; Erec482, Clostridium spp.; Ebac1790, Enterobacter-
iaceae; Bacto1080, Bacteroides-Prevotella group; Hel717, Helicobacter spp.;
Faecali698, Faecalibacterium spp.; Fuso0664, Fusobacterium spp..
FIGURE 3 (A) Three-color fluorescence in situ hybridization (FISH) of
Fusobacterium spp. identified in colonic biopsies of a cat with small
cell GI LSA.Cy-3-labeled Fusobacterium spp. (labeled orange) localized
within adherent mucus of a colonic biopsy specimen. The mucus is
also occupied by other bacteria (total bacteria labeled green with
FITC-Eub). The dark blue structures are epithelial cell nuclei stained
with DAPI.(B) Three-color fluorescence in situ hybridization (FISH) of
Fusobacterium spp. identified in colonic biopsies of a cat with IBD.Cy-
3-labeled Fusobacterium spp. (labeled orange) localized within
adherent mucus of a colonic biopsy specimen. The mucus is also
occupied by other bacteria (total bacteria labeled green with FITC-
Eub). The dark blue structures are epithelial cell nuclei stained
with DAPI
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with this was an expansion of CD11b+ myeloid cells (i.e., dendritic
cells, macrophages, and myeloid-derived suppressor cells) in the neo-
plastic tissues and an NF-κB-driven pro-inflammatory response.41
Similarly, our results also indicated increases in CD11b+ and NF-κB
expressing cells in GI biopsies of cats with small cell GI LSA, and there
was a positive correlation between increased Fusobacterium spp. num-
bers and both CD11b+ and NF-κB expressing cells. Furthermore,
CD11b+ myeloid cells might contribute to development of a tumor
microenvironment,19,63 and Fusobacterium spp. might induce toll like
receptors (TLR), to stimulate NF-κB through the TLR4/MYD88 path-
way.54 Importantly, TLRs are found on both immune and non-immune
cells, and can be expressed on tumors including human mantle cell
lymphoma.21,64
There were also increased numbers of the Bacteroides-Prevotella
bacteria in the ileal biopsies of the cats with small cell GI LSA com-
pared to ileal biopsies of the cats with IBD. Prior studies have shown
that increased Bacteroides spp. can be seen in healthy cats versus cats
with IBD.65,66 This suggests that progressive disease might be
associated with a decreased Bacteroides spp. load. This difference in
findings might be explained by the different sampling sites (mucosal
versus fecal) that were used for Bacteroides spp. quantification,67 or
might be due to the different cohorts compared, considering that
quantification of GI Bacteroides spp. in cats with GI small cell LSA, to
the authors’ knowledge, has not been previously evaluated. Also, as
the Bacteroides spp. incorporates a number of different subspecies,
there is also the possibility that cats with small cell GI LSA harbor
increased numbers of enterotoxigenic Bacteroides spp. as compared to
those with IBD, as occurs in humans.68,69
The additional 5 probes evaluated using FISH included Clostridium
spp. (Erec482), Enterobacteriaceae (Ebac1790), Helicobacter spp.
(Hel717), Faecalibacterium spp. (Faecali896) and total bacteria (Eub338).
Clostridium spp. population and diversity have been shown to be
decreased while Enterobacteriaceae bacteria is increased in humans,
dogs and cats with chronic intestinal inflammation.16,17,65,70–72 Utilizing
16S rRNA sequencing in cats with chronic enteropathies, Faecalibacter-
ium spp. bacteria were decreased while Enterobacteriaceae numbers
were increased in cats with diarrhea.66 This variation of bacterial spe-
cies also occurs in dogs with IBD.72,73 Therefore, different inflammatory
states are characterized by differences in the microbiota. The current
study did not show any significant differences in Enterobacteriaceae,
Faecalibacterium spp. and total bacteria (Eub338) in GI biopsies of cats
with small cell GI LSA compared to GI biopsies of cats with IBD.
Helicobacter spp. induces host responses influencing risk of onco-
genesis, and promotes chronic gut inflammation in humans and
mice.46 In a recent study, FISH showed that the presence of enterohe-
patic helicobacter was significantly associated with poorly
FIGURE 4 (A) Three-color fluorescence in situ hybridization (FISH) of
Bacteroides spp. identified in ileal biopsies of a cat with small cell
GI LSA.Cy-3-labeled Bacteroides spp. (labeled orange) localized within
adherent mucus of an ileal biopsy specimen. The mucus is also
occupied by other bacteria (total bacteria labeled green with FITC-
Eub). The dark blue structures are epithelial cell nuclei stained
with DAPI.(B) Three-color fluorescence in situ hybridization (FISH) of
Bacteroides spp. identified in ileal biopsies of a cat with IBD.Cy-
3-labeled Bacteroides spp. (labeled orange) localized within adherent
mucus of an ileal biopsy specimen. The mucus is also occupied by
other bacteria (total bacteria labeled green with FITC-Eub). The dark
blue structures are epithelial cell nuclei stained with DAPI
FIGURE 5 Mucosal CD11b+ cellular expression in GI biopsies of cats
with IBD compared to cats with small cell GI LSA in the ileum and
colon (total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats).
Boxes show lowest, median, and upper quartiles. Whiskers represent
1.5 of the interquartile range, with means denoted by the black
rhombi and outliers denoted by the black circles. Median mucosal
CD11b+ myeloid cell counts are significantly higher in the ileal
(median = 503; P = .012) and colonic (median = 77; P < .0001)
biopsies of cats with small cell GI LSA compared to the ileal (median =
82.5) and colonic (median = 15) biopsies of cats with IBD
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differentiated large intestinal adenocarcinoma in cats.48 Our results
showed no significant difference in Helicobacter spp. bacterial counts
in GI biopsies of cats with small cell GI LSA compared to GI biopsies
of cats with IBD.
It should be noted that in this study the majority of bacteria eval-
uated were located in the adherent mucus of the GI biobsies, a finding
consistent with a prior study.10 Less bacteria was appreciated in the
free mucus and attaching to the surface epithelium, although still sub-
jectively substantial. In a number of the biopsies there was very mini-
mal to no bacteria appreciated invasively in the mucosa.
Although there is clinical relevance in determining the short and
long-term outcomes and response to treatment of the underlying
enteropathy in cats with alterations in the GI microbiota, we were
unable to fully assess the significance of the relationship of Fusobac-
terium spp. quantification and outcome due to the variation of treat-
ments and the limitation on follow up for a number of these cats. This
is worth assessing in future studies, as in human studies and rodent
models, overabundance of Fusobacterium spp. in patients or rodents
with CRC does appear to have a correlation with poorer prognostic
outcome.36,51,54
There are a number of potential limitations to this study. These
would include the retrospective study design using medical records
completed by different clinicians and the small population of cats
evaluated. As diagnosis of IBD and small cell GI LSA rely as much on
prior history as diagnostic findings the authors included, at a mini-
mum, the most pertinent historical findings that would be needed to
make these diagnoses in light of findings associated with diagnostic
testing performed. The administration of antibiotics that could have
affected the microbiota would be another potential limitation. The
authors attempted to include cats with no history of antibiotic
administration 2 weeks prior to the acquisition of GI biopsies but this
information was not always reported in the medical records. Proces-
sing, including formalin-fixation and paraffin embedding of the biop-
sies, might have also played a role in the finding of bacteria
contained in the adherent mucus compartment, but this is consistent
with a prior study10 and should not have caused a discrepancy in any
1 cat in the study relative to the study population as a whole.
Another potential limitation was the inability to perform PARR on
the formalin-fixed, paraffin embedded tissues of all cats. The authors
acknowledge that both PARR and IHC, when utilized together could
have reduced the underestimation of small cell GI LSA in this popula-
tion and might have allowed for a more sensitive means of screening
for small cell GI LSA amongst the cohorts.2,74 Unfortunately, tissue
specimens were sometimes too limited per each feline endoscopic
biopsy sample to allow for this additional diagnostic, due to the
extensive tissue requirement for both hybridization for FISH and
CD11b+ and NF-κB immunohistochemical assessment. Also, the
expense of performing PARR on all samples in this study would have
been beyond the scope of funds available for the study. The authors
did attempt to circumvent this limitation by performing PARR on any
sample that exhibited questionable lymphoid monomorphism. Fur-
thermore, it has been suggested that although PARR is valuable as a
differentiating diagnostic test, it should be considered as an adjunct
to immunohistochemical and histologic diagnostics, as it also does
have its limitations relative to false negatives.2,74 It has been recom-
mended that PARR be considered as part of a stepwise diagnostic
strategy, indicating the importance of more advanced testing only as
required in a true clinical setting.2,74
In conclusion, we showed that Fusobacterium spp. bacteria are
increased in the ileum and colon of GI biopsies of cats with small cell
GI LSA relative to GI biopsies of cats with IBD. We also showed that
increased Fusobacterium spp. bacteria are positively correlated to
increased CD11b+ and NF-κB expression in neoplastic ileal and
colonic biopsies versus ileal and colonic biopsies of cats with lympho-
plasmacytic ileitis and colitis (idiopathic IBD). Future studies would be
needed to attempt to further clarify whether increased Fusobacterium
spp is a consequence of small cell GI LSA in cats or whether it plays a
role in the development of the disease.
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FIGURE 6 Mucosal NF-κB cellular expression in GI biopsies of cats
with IBD compared to cats with small cell GI LSA in the ileum and
colon (total = 28 cats; IBD = 14 cats; small cell GI LSA = 14 cats).
Boxes show lowest, median, and upper quartiles. Whiskers represent
1.5 of the interquartile range, with means denoted by the black
rhombi and outliers denoted by the black circles. Median NF-κB
mucosal expression is significantly higher in the ileal (median = 750;
P = .0055) and colonic (median = 154; P < .0001) biopsies of cats with
small cell GI LSA when compared to the ileal (median = 169) and
colonic (median = 49.5) biopsies of cats with IBD
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